We are live on
!
Find out more
LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$2.63B
1-Year Est. Return
31.52%
This Fund
S&P 500
This Quarter
Est. Return
+3.62%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$419M
AUM Growth
-$317M
(-43%)
Cap. Flow
-$354M
Cap. Flow
% of AUM
-84.51%
Top 10 Holdings %
Top 10 Hldgs %
46.13%
Holding
314
New
25
Increased
10
Reduced
26
Closed
212
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackrock
BLK
|
+$14.6M |
| 2 |
CELG
Celgene Corp
CELG
|
+$11.6M |
| 3 |
Brunswick
BC
|
+$9.55M |
| 4 |
Zimmer Biomet
ZBH
|
+$6.19M |
| 5 |
iShares MSCI India ETF
INDA
|
+$5.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum! Brands
YUM
|
+$20.4M |
| 2 |
CVS Health
CVS
|
+$19.2M |
| 3 |
Alibaba
BABA
|
+$16.4M |
| 4 |
CBD
Companhia Brasileira de Distribuicao
CBD
|
+$15.3M |
| 5 |
Pfizer
PFE
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.12% |
| 2 | Consumer Discretionary | 14.21% |
| 3 | Consumer Staples | 10.82% |
| 4 | Real Estate | 5.19% |
| 5 | Financials | 4.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
26
DELISTED
Hologic
HOLX
| $3.11M | 0.74% |
+80,000
| New | +$3.02M |
|
|
NUVA
27
DELISTED
NuVasive, Inc.
NUVA
| $3.07M | 0.73% |
+46,000
| New | +$2.93M |
|
|
WBMD
28
DELISTED
WebMD Health Corp.
WBMD
| $2.98M | 0.71% |
+60,000
| New | +$3.31M |
|
29
Integra LifeSciences
IART
$1.35B
| $2.97M | 0.71% |
+72,000
| New | +$3.02M |
|
30
Morgan Stanley
MS
$342B
| $2.82M | 0.67% |
+88,000
| New | +$2.62M |
|
31
Toro Company
TTC
$9.32B
| $2.81M | 0.67% |
60,000
-180,000
| -75% | -$8.42M |
|
32
Coherus Oncology
CHRS
$181M
| $2.68M | 0.64% |
100,000
-9,664
| -9% | -$264K |
|
33
Halozyme
HALO
$11.6B
| $2.39M | 0.57% |
+200,000
| New | +$2.04M |
|
34
NXP Semiconductors
NXPI
$58.9B
| $2.33M | 0.55% |
+22,796
| New | +$1.93M |
|
35
Edwards Lifesciences
EW
$53.6B
| $2.12M | 0.51% |
52,800
+16,170
| +44% | +$609K |
|
|
ABMD
36
DELISTED
Abiomed Inc
ABMD
| $2.06M | 0.49% |
+16,000
| New | +$1.92M |
|
37
Bio-Rad Laboratories Class A
BIO
$9.68B
| $2.05M | 0.49% |
+12,500
| New | +$1.9M |
|
38
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $2.03M | 0.48% |
+53,840
| New | +$2M |
|
39
Surgery Partners
SGRY
$2.01B
| $2.02M | 0.48% |
100,000
-30,000
| -23% | -$551K |
|
|
40
Alibaba
BABA
$300B
| $1.99M | 0.47% |
18,800
-176,800
| -90% | -$16.4M |
|
|
41
Pfizer
PFE
$150B
| $1.69M | 0.4% |
52,700
-436,099
| -89% | -$14.6M |
|
42
Fomento Económico Mexicano
FMX
$40B
| $1.44M | 0.34% |
15,600
-150,400
| -91% | -$13.9M |
|
|
CBD
43
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $1.2M | 0.29% |
73,000
-962,291
| -93% | -$15.3M |
|
44
iShares MSCI Emerging Markets ETF
EEM
$30.4B
| $1.04M | 0.25% |
+27,800
| New | +$1.02M |
|
|
45
Yum! Brands
YUM
$41B
| $1.01M | 0.24% |
15,440
-319,082
| -95% | -$20.4M |
|
46
Pricesmart
PSMT
$5.49B
| $695K | 0.17% |
8,300
-68,700
| -89% | -$5.66M |
|
|
NBIS
47
Nebius Group N.V.
NBIS
$65.8B
| $653K | 0.16% |
+31,000
| New | +$674K |
|
48
Arcos Dorados Holdings
ARCO
$1.66B
| $606K | 0.14% |
118,200
-1,526,318
| -93% | -$7.92M |
|
49
iShares MSCI Peru and Global Exposure ETF
EPU
$550M
| $501K | 0.12% |
+15,100
| New | +$507K |
|
50
iShares MSCI Turkey ETF
TUR
$221M
| $447K | 0.11% |
+11,800
| New | +$456K |
|
Similar funds
SI
WWM
ACM
CCM
MG
PCMI
PCIG
MAMU
Lombard Odier Asset Management (Switzerland)'s Q3 2016 Portfolio in Review
As of Q3 2016, Lombard Odier Asset Management (Switzerland) held 314 positions worth $419M, down 43% from $736M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lombard Odier Asset Management (Switzerland) withdrew a net $354M in Q3 2016, closing 212 positions and reducing 26 holdings. Its most notable exit was CVS Health, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 41% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, Lombard Odier Asset Management (Switzerland) opened a new position in Blackrock worth $14.5M.
- Lombard Odier Asset Management (Switzerland)'s largest Q3 2016 buy was Blackrock: 40,000 shares worth $14.5M.
- Lombard Odier Asset Management (Switzerland) added most to Celgene Corp in Q3 2016, an estimated $11.6M increase.
- Lombard Odier Asset Management (Switzerland)'s biggest Q3 2016 reduction was Yum! Brands, cutting an estimated $20.4M.
- Lombard Odier Asset Management (Switzerland) fully exited CVS Health in Q3 2016, selling an estimated $19.2M.
- Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 46% of its $419M portfolio in Q3 2016.
- Lombard Odier Asset Management (Switzerland) opened 25 new positions and closed 212 in Q3 2016.
- Lombard Odier Asset Management (Switzerland)'s portfolio value fell 43% quarter-over-quarter to $419M.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q3 2016, filed 15 Nov 2016.